Stock Market News 2025-09-17
535 news published.
Biotech: late‑stage wins reshape immunology and dermatology bets
Regeneron (REGN) posted a blockbuster Phase 3 win in fibrodysplasia ossificans progressiva (FOP), where garetosmab prevented more than 99% of abnormal bone formation—an outcome that could reprice rare‑disease economics and spark M&A interest around targeted antibodies. Read the release.
Roivant / Priovant (ROIV) strengthened its late‑stage dossier with positive Phase 3 VALOR results for brepocitinib in dermatomyositis, showing durable benefit at 52 weeks—a regulatory momentum builder that narrows competitive risk in autoimmune dermatology. Details here.
Johnson & Johnson (JNJ) unveiled head‑to‑head data where icotrokinra outperformed deucravacitinib in plaque psoriasis—one of the few direct class comparisons to date and a data point investors will watch for potential market‑share shifts. Trial report.
Arvinas (ARVN) provided an update on its collaboration with Pfizer (PFE) and announced actions to support value creation, a reminder that strategic pharma partnerships can accelerate timelines and derisk assets for investors. Read the notice.
Biogen (BIIB) received European Commission approval for ZURZUVAE® (zuranolone), the first treatment approved for women with postpartum depression in Europe—an approval that opens a new commercial market and sets a precedent for neuropsychiatric launches. Regulatory release.
Big Pharma & obesity drugs: competitive catalysts
Eli Lilly (LLY) reported that oral GLP‑1 orforglipron beat oral semaglutide in a head‑to‑head trial, escalating the stakes in obesity and diabetes franchises and pressuring long‑term growth assumptions for incumbent GLP‑1 players. Study details.
Adding to the GLP‑1 narrative, Lilly (LLY) also announced that Mounjaro (tirzepatide) reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes—data that could broaden the drug's label and long‑term market opportunity if regulators follow. Trial release.
Clinical & translational updates to watch
Elicio Therapeutics (ELTX) said ELI‑002 7P induced mKRAS‑specific T‑cell responses in 99% of evaluable patients in Phase 2—an encouraging translational signal that could re‑ignite interest in neoantigen vaccine approaches. Study note.
NANOBIOTIX (NBTX) released new Phase 1 results evaluating JNJ‑1900 (NBTXR3) with immune checkpoint inhibitors in primary cutaneous melanoma resistant to anti‑PD‑1, offering early signals on combination radiosensitizer strategies. Results.
Corporate tech, AI agents and marketing platforms
Zoom (ZM) introduced AI Companion 3.0, pushing agentic AI deeper into meetings and workflows—an upgrade that could boost enterprise engagement and open new monetization avenues. Event coverage.
CrowdStrike (CRWD) launched Threat AI, aiming to automate detection and response with agentic threat intelligence—relevant as buyers seek scalable cybersecurity amid rising incidents. Product note.
PayPal (PYPL) struck a multiyear pact with Google to smooth commerce across search and payments—a distribution play that could accelerate checkout adoption and shift flows for online merchants. Partnership details.
Financials & capital markets: buybacks, fintech and treasury experiments
S&P Global (SPGI) data shows S&P 500 buybacks dropped roughly 20% to $235 billion in Q2—an important liquidity signal that may affect short‑term market support until buybacks recover. Report.
Pagaya (PGY) closed an upsized $600 million PAID deal, boosting origination capacity and fee revenue potential for the fintech—a notable capital markets win for platform growth. Deal announcement.
Reliance Global Group (RELI) completed an initial Ethereum purchase as part of a corporate digital‑asset treasury move—an example of growing, though still experimental, crypto allocations on corporate balance sheets. Announcement.
CooperCompanies (COO) announced an expanded share repurchase program, a shareholder‑friendly move that can support earnings per share and signal confidence in long‑term margins for medical‑device investors. Program details.
Energy, industrials and commodity moves
NRG Energy (NRG) raised 2025 guidance and scheduled a Q3 earnings call, a sign utility and power producers are benefiting from tighter fundamentals and favorable commodity spreads. Guidance note.
Nucor (NUE) issued guidance for the third quarter of 2025, an important read for cyclicals as steel demand and pricing dynamics continue to influence industrial earnings and capex plans. Guidance.
Green Plains (GPRE) entered an agreement with Freepoint Commodities to monetize 45Z tax credits, improving near‑term liquidity and illustrating creative balance‑sheet solutions for biofuel producers. Deal terms.
Ballard Power Systems (BLDP) will launch the FCmove®‑SC fuel cell at Busworld, touting improved performance and lifecycle cost on the road to diesel parity—news that matters for fleet electrification economics and transport OEM adoption. Product release.
Digital infrastructure & data‑center moves
Gorilla (GRRR) secured a $1.4 billion contract to build Freyr Singapore's AI data‑center backbone—one of the larger regional infrastructure awards highlighting sustained capex for AI compute. Contract details.
OTG Acquisition Corp. I (OTGAU) closed a $230 million SPAC focused on the digital infrastructure ecosystem, backed by Expedition Infrastructure Partners—a sign that investors are still channeling capital into data‑center and fiber consolidation plays. Deal announcement.
STMicroelectronics (STM) is advancing chip packaging with a PLP pilot line in France, signaling continued investment in heterogeneous integration and supply‑chain resilience for advanced nodes. More.
Quantum, optics and advanced tech orders
IonQ (IONQ) completed the Oxford Ionics acquisition and flagged intent to acquire Vector Atomic, while also signing an MOU with the U.S. Department of Energy to advance quantum technologies in space—moves that broaden IonQ's scope from computing into sensing, instrumentation and government‑backed projects. Closed deal · Intent · MOU details.
LightPath Technologies (LPTH) won a $22.1 million follow‑on order for infrared camera systems—an order that adds near‑term revenue visibility in defense and aerospace optics. Order details.
Semiconductors, hardware and data‑center infrastructure
Gorilla (GRRR)'s Freyr contract appears alongside broader infrastructure funding as chipmakers and integrators plan capacity to meet AI demand; watch supplier backlog and component lead times for margin pressure across the stack. Contract.
STMicroelectronics (STM) continues to push packaging and pilot lines, which investors view as a hedge against node concentration and a driver for differentiated product roadmaps. Details.
Selected earnings and corporate results
Cracker Barrel (CBRL) reported fourth quarter and full‑year fiscal 2025 results and provided updated outlook—important for consumer‑restaurant cyclicality and same‑store traffic trends as operators navigate labor and commodity costs. Earnings release.
Sangoma (SANG) announced fourth quarter and fiscal year 2025 results—investors will parse margins and recurring revenue growth for the communications‑software peer set. Report.
Nano Dimension (NNDM) announced second‑quarter 2025 financials—data investors will parse for signs of traction in additive electronics and industrial 3D printing markets. Quarterly report.
Bullish (BLSH) posted second‑quarter 2025 results—worth watching for crypto exchange metrics and revenue mix amid volatile trading volumes. Earnings.
Selected corporate and capital notices
Kayne Anderson Energy Infrastructure Fund (KYN) priced a private placement of $100 million of notes—an example of yield‑oriented funds tapping debt markets to fund energy infrastructure investments. Offering note.
Red Cat Holdings (RCAT) announced a proposed public offering of common stock, a capital raise that investors will watch for dilution and how proceeds support growth in unmanned systems. Filing.
Albertsons® Companies, Inc. (ACI) announced board changes—governance updates that can influence strategic choices for the supermarket chain as it navigates margins and consolidation in grocery. Board notice.
What to watch next
Focus remains on regulatory readouts for immunology trials, GLP‑1 competitive data and label expansion potential, plus guidance from cyclicals like steel and power companies. Track buyback trends and corporate treasury experiments with crypto, while digital‑infrastructure funding and quantum partnerships could reshape capital allocation across tech and industrial names. Upcoming earnings from retailers and industrial tech will guide near‑term sector rotations.
Don't miss out on market-moving news. Bookmark this page and check back regularly for the most recent updates on stocks, sectors, and the overall market landscape. Stay informed, stay ahead, and make smarter investment choices with our comprehensive stock news coverage.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement